LOS ANGELES, Calif., June 26, 2024 – AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Amalgam Rx, Inc., a leader in enabling...

WILMINGTON, DE — October 5, 2023 —Amalgam Rx, Inc., a leader in enabling data-driven health care decision making, announced the participation of CVS Health Ventures in its Series B investment round. The investment supports the scaling of Amalgam’s EHR-integrated...

WILMINGTON, DE, December 19, 2022 -- Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the expansion of its global agreement with Novo Nordisk for...

New York — Dec 7, 2022 — CB Insights today named Amalgam Rx to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022. "From reimagining clinical care, to leveraging tech like AR/VR to improve surgical...

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, announced that our insulin titration solution, DoseCheck, will now help patients and their care teams manage...

Global Health & Pharma recently presented their seventh annual Biotechnology Awards and named Amalgam the Best SaaS-Enabled Digital Health Platform. The Global Health & Pharma Biotechnology Awards are given strictly on merit, so we’re extremely honored to be...

WILMINGTON, DE — Feb 16, 2022 —Amalgam Rx, Inc., a leader in connecting healthcare providers, payers, and life sciences companies through a SaaS-enabled digital marketplace and product platform, and Privia Health Group, Inc., a national physician enablement company,...

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, announced a collaboration with the AWS for Health initiative from Amazon Web Services (AWS) to accelerate the...

WILMINGTON, DE — Jun 16, 2021 —Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing global expansion of its insulin titration solution with Novo...

WILMINGTON, DE — Jun 16, 2021 —Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing it has achieved the Conformité Européenne (CE) Mark for its...

WILMINGTON, DE — May 19, 2021 —Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the acquisition of the assets of Geetha, LLC, an adaptive,...

WILMINGTON, DE — March 17, 2021 —Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the appointment of Jennifer Main as chief operating officer...

WILMINGTON, DE — January 13, 2021 —Amalgam Rx, Inc., a leading Digital Therapeutics and Patient Support company, announces the acquisition of Avhana Health, a privately held clinical decision support (CDS) company, which has deep integrations with the leading...

WILMINGTON, DE — December 16, 2020 —Amalgam Rx, Inc., a leading Digital Therapeutics and Patient Support company, is announcing the hiring of a new president, Chris Bergstrom, former partner and head of digital therapeutics at Boston Consulting Group, and the...